Advertisement
Australia markets closed

  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     

  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     

  • AUD/USD

    0.6498
    -0.0002 (-0.04%)
     

  • OIL

    82.66
    -0.15 (-0.18%)
     

  • GOLD

    2,328.60
    -9.80 (-0.42%)
     

  • Bitcoin AUD

    99,200.54
    -3,473.40 (-3.38%)
     

  • CMC Crypto 200

    1,395.33
    -28.77 (-2.02%)
     

  • AUD/EUR

    0.6070
    -0.0001 (-0.01%)
     

  • AUD/NZD

    1.0945
    +0.0003 (+0.03%)
     

  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     

  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     

  • DAX

    18,088.70
    -48.95 (-0.27%)
     

  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     

  • NIKKEI 225

    37,961.60
    -498.48 (-1.30%)
     

Company News for Sep 21, 2020

Zacks Equity Research
·1-min read

  • Shares of Roche Holding AG RHHBY rose 1% after the company reported that hospitalized COVID-19 patients taking rheumatoid arthritis drug Actemra were less likely to need mechanical ventilation than those receiving placebo.

  • Shares of Pivotal Investment Corporation II PIC surged 14.3% after the company reported a merger deal with XL Fleet which holds an enterprise value of $1 billion.

  • Shares of Immutep Limited IMMP jumped 18.1% after the company reported improving results from Stage I of Phase II TACTI-002 study.

  • Shares of J. Alexander's Holdings, Inc. JAX rose 21.5% after the company reported that sales volumes for the first three weeks of September averaged 90% of that of 2019 sales.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Roche Holding AG (RHHBY) : Free Stock Analysis Report
 
Prima BioMed Ltd (IMMP) : Free Stock Analysis Report
 
J. Alexanders Holdings, Inc. (JAX) : Free Stock Analysis Report
 
Pivotal Investment Corporation II (PIC) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research